Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

Hims & Hers Health (HIMS) has disclosed plans to shut down Apostrophe, its acne treatment business. This change is part of ...

Wall Street's major averages dipped for the week as investors wrestled with tariff twists from the Trump administration. The ...

An increasing share of the population is living in retirement for longer periods of time, offering "specific market ...